Cargando…
Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study
Atopic dermatitis (AD) has been shown to be closely related to gut dysbiosis mediated through the gut–skin axis, and thus the gut microbiome has recently been explored as a potential therapeutic target for the treatment of AD. Contrasting and varying efficacy have been reported since then. In order...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687608/ https://www.ncbi.nlm.nih.gov/pubmed/36428472 http://dx.doi.org/10.3390/biomedicines10112904 |
_version_ | 1784836049187373056 |
---|---|
author | Wang, Yiwei Choy, Chi Tung Lin, Yufeng Wang, Lin Hou, Jinpao Tsui, Joseph Chi Ching Zhou, Junwei Wong, Chi Ho Yim, Tai Ki Tsui, Wai Kai Chan, Un Kei Siu, Pui Ling Kella Loo, Steven King Fan Tsui, Stephen Kwok Wing |
author_facet | Wang, Yiwei Choy, Chi Tung Lin, Yufeng Wang, Lin Hou, Jinpao Tsui, Joseph Chi Ching Zhou, Junwei Wong, Chi Ho Yim, Tai Ki Tsui, Wai Kai Chan, Un Kei Siu, Pui Ling Kella Loo, Steven King Fan Tsui, Stephen Kwok Wing |
author_sort | Wang, Yiwei |
collection | PubMed |
description | Atopic dermatitis (AD) has been shown to be closely related to gut dysbiosis mediated through the gut–skin axis, and thus the gut microbiome has recently been explored as a potential therapeutic target for the treatment of AD. Contrasting and varying efficacy have been reported since then. In order to investigate the determining factor of probiotics responsiveness in individuals with AD, we initiated the analysis of 41 AD patients with varying disease severity in Hong Kong, whereas the severity was assessed by Eczema Area and Severity Index (EASI) by board certified dermatologist. 16S rRNA sequencing on the fecal samples from AD patients were performed to obtain the metagenomics profile at baseline and after 8 weeks of oral administration of a novel E3 probiotics formula (including prebiotics, probiotics and postbiotics). While EASI of the participants were significantly lower after the probiotics treatment (p < 0.001, paired Wilcoxon signed rank), subjects with mild AD were found to be more likely to respond to the probiotics treatment. Species richness among responders regardless of disease severity were significantly increased (p < 0.001, paired Wilcoxon signed rank). Responders exhibited (1) elevated relative abundance of Clostridium, Fecalibacterium, Lactobacillus, Romboutsia, and Streptococcus, (2) reduced relative abundance of Collinsella, Bifidobacterium, Fusicatenibacter, and Escherichia-Shigella amid orally-intake probiotics identified using the machine learning algorithm and (3) gut microbiome composition and structure resembling healthy subjects after probiotics treatment. Here, we presented the gut microbiome dynamics in AD patients after the administration of the E3 probiotics formula and delineated the unique gut microbiome signatures in individuals with AD who were responding to the probiotics. These findings could guide the future development of probiotics use for AD management. |
format | Online Article Text |
id | pubmed-9687608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96876082022-11-25 Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study Wang, Yiwei Choy, Chi Tung Lin, Yufeng Wang, Lin Hou, Jinpao Tsui, Joseph Chi Ching Zhou, Junwei Wong, Chi Ho Yim, Tai Ki Tsui, Wai Kai Chan, Un Kei Siu, Pui Ling Kella Loo, Steven King Fan Tsui, Stephen Kwok Wing Biomedicines Article Atopic dermatitis (AD) has been shown to be closely related to gut dysbiosis mediated through the gut–skin axis, and thus the gut microbiome has recently been explored as a potential therapeutic target for the treatment of AD. Contrasting and varying efficacy have been reported since then. In order to investigate the determining factor of probiotics responsiveness in individuals with AD, we initiated the analysis of 41 AD patients with varying disease severity in Hong Kong, whereas the severity was assessed by Eczema Area and Severity Index (EASI) by board certified dermatologist. 16S rRNA sequencing on the fecal samples from AD patients were performed to obtain the metagenomics profile at baseline and after 8 weeks of oral administration of a novel E3 probiotics formula (including prebiotics, probiotics and postbiotics). While EASI of the participants were significantly lower after the probiotics treatment (p < 0.001, paired Wilcoxon signed rank), subjects with mild AD were found to be more likely to respond to the probiotics treatment. Species richness among responders regardless of disease severity were significantly increased (p < 0.001, paired Wilcoxon signed rank). Responders exhibited (1) elevated relative abundance of Clostridium, Fecalibacterium, Lactobacillus, Romboutsia, and Streptococcus, (2) reduced relative abundance of Collinsella, Bifidobacterium, Fusicatenibacter, and Escherichia-Shigella amid orally-intake probiotics identified using the machine learning algorithm and (3) gut microbiome composition and structure resembling healthy subjects after probiotics treatment. Here, we presented the gut microbiome dynamics in AD patients after the administration of the E3 probiotics formula and delineated the unique gut microbiome signatures in individuals with AD who were responding to the probiotics. These findings could guide the future development of probiotics use for AD management. MDPI 2022-11-11 /pmc/articles/PMC9687608/ /pubmed/36428472 http://dx.doi.org/10.3390/biomedicines10112904 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wang, Yiwei Choy, Chi Tung Lin, Yufeng Wang, Lin Hou, Jinpao Tsui, Joseph Chi Ching Zhou, Junwei Wong, Chi Ho Yim, Tai Ki Tsui, Wai Kai Chan, Un Kei Siu, Pui Ling Kella Loo, Steven King Fan Tsui, Stephen Kwok Wing Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study |
title | Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study |
title_full | Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study |
title_fullStr | Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study |
title_full_unstemmed | Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study |
title_short | Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study |
title_sort | effect of a novel e3 probiotics formula on the gut microbiome in atopic dermatitis patients: a pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687608/ https://www.ncbi.nlm.nih.gov/pubmed/36428472 http://dx.doi.org/10.3390/biomedicines10112904 |
work_keys_str_mv | AT wangyiwei effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT choychitung effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT linyufeng effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT wanglin effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT houjinpao effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT tsuijosephchiching effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT zhoujunwei effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT wongchiho effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT yimtaiki effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT tsuiwaikai effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT chanunkei effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT siupuilingkella effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT loostevenkingfan effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy AT tsuistephenkwokwing effectofanovele3probioticsformulaonthegutmicrobiomeinatopicdermatitispatientsapilotstudy |